Society of urologic oncology biotechnology forum: New approaches and targets for advanced prostate cancer

Purpose: We provide an overview of advances in molecular based therapeutic strategies for prostate cancer and summarize the studies presented at the S ociety of Urologic Oncology Biotechnology Forum in 2000. Materials and Methods: Three promising new treatment strategies are present ed, and a critique of the advantages and limitations of each is offered by a leading expert in the field. Results: Treatment results and the current state of dendritic cell based im munotherapy, monoclonal antibody therapy and anti-apoptotic treatment appro aches are presented. Conclusions: Currently patients with advanced prostate carcinoma have expan ded therapeutic options available in the form of molecular based phases II and III clinical trials.